Genenta Science S.p.A.
NASDAQ:GNTA
5.3 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -11.407 | -8.478 | -5.529 | -5.592 | -4.598 |
| Depreciation & Amortization
| 0.042 | 0.006 | 0.005 | 0.002 | 0 |
| Deferred Income Tax
| -0.823 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0.74 | 0.723 | 0.497 | 0.46 | 0.75 |
| Change In Working Capital
| -0.409 | 0.24 | -1.944 | -0.921 | 1.353 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -0.728 | 1.004 | -0.365 | -0.017 | -0.028 |
| Other Working Capital
| 0.319 | -0.764 | -1.579 | -0.903 | 1.381 |
| Other Non Cash Items
| 0.882 | 0.09 | 0.013 | 0.006 | 0.005 |
| Operating Cash Flow
| -10.975 | -7.418 | -6.958 | -6.045 | -2.49 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0.014 | -0.027 | -0.009 | -0.021 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -14.574 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -0 | -27.07 | -9.009 | 0 | 0 |
| Investing Cash Flow
| -14.587 | -0.027 | -0.009 | -0.021 | 0 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0.001 | 0 | 28.742 | 1.5 | 15.087 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | 0 | 0.001 | -0.111 | -0.319 |
| Financing Cash Flow
| 0.001 | 0 | 28.742 | 1.389 | 14.768 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| -0.006 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -26.017 | -7.445 | 21.775 | -4.676 | 12.278 |
| Cash At End Of Period
| 3.694 | 29.795 | 37.24 | 15.465 | 20.141 |